Expression of hemagglutinin/esterase by a mouse hepatitis virus coronavirus defective-interfering RNA alters viral pathogenesis

Virology

Volumn 242, Issue 1, 1998, Pages 170-183

  Zhang, Xuming ^a,b   Hinton, David R ^a   Park, Sungmin ^a   Parra, Beatriz ^a   Liao, Ching Len ^a,c   Lai, Michael M C ^a   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; HEMAGGLUTININ;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS INFECTION; VIRUS EXPRESSION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION;

ANIMALIA; CORONAVIRUS; FELIS CATUS; MURINAE; MURINE HEPATITIS VIRUS; RNA VIRUSES;

EID: 0032029766     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8993     Document Type: Article

References (46)

1. b-restricted cytotoxic T cell response. J. Gen. Virol. 77:1996;315-325.
2. Bos E. C., Luytjes W., van der Meulen H. V., Koerten H. K., Spaan W. J. The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology. 218:1996;52-60.
3. Cua D. J., Hinton D. R., Stohlman S. A. Self-antigen-induced TH2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J. Immunol. 155:1995;4052-4059.
4. Deregt D., Babiuk L. A. Monoclonal antibodies to bovine coronavirus: Characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology. 161:1987;410-420.
5. Fleming J. O., Stohlman S. A., Harmon R. C., Lai M. M. C., Frelinger J. A., Weiner L. P. Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 131:1983;296-307.
6. Gagneten S., Gout O., Dubois-Dalcq M., Rottier P., Rossen J., Holmes K. V. Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein. J. Virol. 69:1995;889-895.
7. Herrler G., Rott R., Klenk H. D., Muller H. P., Shukla A. K., Schauer R. The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J. 4:1985;1503-1506.
8. Herrler G., Durkop I., Becht H., Klenk H. D. The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. J. Gen. Virol. 69:1988;839-846.
9. Hirano N., Fujiwara K., Hino S., Matsumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:1974;298-302.
10. Joseph J., Grun J. L., Lublin F. D., Knobler R. L. Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM). J. Neuroimmunol. 42:1993;47-52.
11. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
12. La Monica N., Yokomori K., Lai M. M. C. Coronavirus mRNA synthesis: Identification of novel transcription initiation signals which are differentially regulated by different leader sequences. Virology. 188:1992;402-407.
13. Lai M. M. C., Brayton P. R., Armen R. C., Patton C. D., Pugh C., Stohlman S. A. Mouse hepatitis virus A59: Messenger RNA structure and genetic localization of the sequence divergence from the hepatotropic strain MHV3. J. Virol. 39:1981;823-834.
14. Lai M. M. C., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 48:1997;1-100.
15. Lai M. M. C., Patton C. D., Baric R. S., Stohlman S. A. Presence of leader sequences in the mRNA of mouse hepatitis virus. J. Virol. 46:1983;1027-1033.
16. Lai M. M. C., Baric R. S., Brayton P. R., Stohlman S. A. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc. Natl. Acad. Sci. USA. 81:1984;3626-3630.
17. Lavi E., Gilden D. H., Highkin M. K., Weiss S. R. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab. Anim. Sci. 36:1986;130-135.
18. Lavi E., Gilden D. H., Wroblewska Z., Rorke L. B., Weiss S. R. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 34:1984;597-603.
19. Lee H. J., Shieh C. K., Gorbalenya A. E., Koonin E. V., La Monica N., Tuler J., Bagdzhadzhyan A., Lai M. M. C. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology. 180:1991;567-582.
20. Leibowitz J. L., Wilhemsen K. C., Bond C. W. The virus-specific intracellular RNA species of two murine coronaviruses: MHV-A59 and MHV-JHM. Virology. 114:1981;39-51.
21. Liao C.-L., Lai M. M. C. Requirement of the 5′-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J. Virol. 68:1994;4727-4737.
22. Liao C.-L., Zhang X. M., Lai M. M. C. Coronavirus defective-interfering RNA as an expression vector: The generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase. Virology. 208:1995;319-327.
23. Luytjes W., Bredenbeek P. J., Noten A. F., Horzinek M. C., Spaan W. J. Sequence of mouse hepatitis virus A59 mRNA 2: Indications for RNA recombination between coronaviruses and influenza C virus. Virology. 166:1988;415-422.
24. Makino S., Fujioka N., Fujiwara K. Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J. Virol. 54:1985;329-336.
25. Makino S., Joo M., Makino J. K. A system for study of coronavirus mRNA systhesis: A regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65:1991;6031-6041.
26. Makino S., Lai M. M. C. Evolution of the 5′-end of genomic RNA of murine coronaviruses during passages in vitro. Virology. 169:1989;227-232.
27. Makino S., Shieh C.-K., Keck J. G., Lai M. M. C. Defective interfering particles of murine coronavirus: Mechanism of transcription of defective viral RNA. Virology. 163:1988;104-111.
28. Makino S., Shieh C.-K., Soe L. H., Baker S. C., Lai M. M. C. Primary structure and translation of a defective-interfering RNA of murine coronavirus. Virology. 166:1988;550-560.
29. Parr R. L., Fung L., Reneker J., Myers-Mason N., Leibowitz J. L., Levy G. A. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J. Virol. 69:1995;5033-5038.
30. Parra B., Hinton D. R., Lin M. T., Cua D. J., Stohlman S. A. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology. 233:1997;260-270.
31. Pearce B. D., Hobbs M. V., McGraw T. S., Buchmeier M. Cytokine induction during T-cell mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68:1997;5483-5495.
32. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315-325.
33. Shieh C. K., Lee H. J., Yokomori K., La M. N., Makino S., Lai M. M. C. Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J. Virol. 63:1989;3729-3736.
34. Stohlman S. A., Hinton D. R., Cua D., Dimacali E., Sensintaffar J., Hofman F. M., Tahara S. M., Yao Q. Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J. Virol. 69:1995;5898-5903.
35. Sturman L. S., Holmes K. V. The molecular biology of coronaviruses. Adv. Virus Res. 28:1983;35-112.
36. +. Virology. 225:1996;339-346.
37. Van Snick J. Interleukin-6: An overview. Annu. Rev. Immunol. 8:1990;253-278.
38. Vennema H., Godeke G. J., Rossen J. W., Voorhout W. F., Horzinek M. C., Opstelten D. J., Rottier P. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15:1996;2020-2028.
39. Vlasak R., Luytjes W., Lieder J., Spaan W. J. M., Palese P. The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J. Virol. 62:1988;4686-4690.
40. Yokomori K., Asanaka M., Stohlman S. A., Makino S., Shubin R. A., Gilmore W., Weiner L. P., Wang F.-I., Lai M. M. C. Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J. Neurovirol. 1:1995;330-339.
41. Yokomori K., Baker S. C., Stohlman S. A., Lai M. M. C. Hemagglutinin-esterase specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J. Virol. 66:1992;2865-2874.
42. Yokomori K., Banner L., Lai M. M. C. Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology. 183:1991;647-657.
43. Yokomori K., La Monica N., Makino S., Shieh C.-K., Lai M. M. C. Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology. 173:1989;683-691.
44. Zhang X. M., Hinton D. R., Cua D. J., Stohlman S. A., Lai M. M. C. Expression of interferon-gamma by a coronavirus defective-interfering RNA vector and its effect on viral replication, spread, and pathogenicity. Virology. 233:1997;327-338.
45. Zhang X. M., Lai M. M. C. Unusual heterogeneity of leader-mRNA fusion in a murine coronavirus: Implications for the mechanism of RNA transcription and recombination. J. Virol. 68:1994;6626-6633.
46. Zhang X. M., Liao C.-L., Lai M. M. C. Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both intranscis. J. Virol. 68:1994;4738-4746.